Torii Pharmaceutical Co., Ltd. (TYO:4551)
Japan flag Japan · Delayed Price · Currency is JPY
6,340.00
+10.00 (0.16%)
Jun 6, 2025, 3:30 PM JST

Torii Pharmaceutical Ratios and Metrics

Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
177,983132,36499,80081,80580,79490,395
Upgrade
Market Cap Growth
12.09%32.63%22.00%1.25%-10.62%5.32%
Upgrade
Enterprise Value
137,24292,37755,05022,63914,18118,444
Upgrade
Last Close Price
6340.004715.003450.852735.892611.312868.74
Upgrade
PE Ratio
32.0826.2524.2320.7423.9525.86
Upgrade
PS Ratio
2.892.191.831.671.722.17
Upgrade
PB Ratio
1.471.090.830.690.690.79
Upgrade
P/TBV Ratio
1.471.090.830.690.690.79
Upgrade
P/FCF Ratio
-37.96-35.57--
Upgrade
P/OCF Ratio
-36.37-33.80--
Upgrade
EV/Sales Ratio
2.231.531.010.460.300.44
Upgrade
EV/EBITDA Ratio
18.2612.8210.023.782.803.47
Upgrade
EV/EBIT Ratio
19.2813.5910.934.093.053.89
Upgrade
EV/FCF Ratio
-26.49-9.84--
Upgrade
Debt / Equity Ratio
-0.000.000.000.000.00
Upgrade
Debt / EBITDA Ratio
-0.060.040.090.100.06
Upgrade
Debt / FCF Ratio
-0.12-0.23--
Upgrade
Asset Turnover
0.460.440.410.370.370.31
Upgrade
Inventory Turnover
2.622.893.242.882.852.72
Upgrade
Quick Ratio
4.654.105.806.197.089.41
Upgrade
Current Ratio
6.235.217.056.937.8610.23
Upgrade
Return on Equity (ROE)
4.62%4.17%3.44%3.34%2.91%3.06%
Upgrade
Return on Assets (ROA)
3.30%3.10%2.36%2.62%2.27%2.23%
Upgrade
Return on Capital (ROIC)
3.70%3.51%2.62%2.92%2.50%2.59%
Upgrade
Return on Capital Employed (ROCE)
5.80%5.50%4.20%4.60%3.90%4.10%
Upgrade
Earnings Yield
3.12%3.81%4.13%4.82%4.18%3.87%
Upgrade
FCF Yield
-2.63%-3.29%2.81%-0.38%-4.13%
Upgrade
Dividend Yield
1.89%-----
Upgrade
Payout Ratio
-72.47%85.94%34.18%39.95%38.54%
Upgrade
Buyback Yield / Dilution
-0.02%-0.02%-0.03%-0.02%-0.03%-0.04%
Upgrade
Total Shareholder Return
1.87%-0.02%-0.03%-0.02%-0.03%-0.04%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.